ITI-7000 / HLB Bio Group, Immunomic Therapeutics - LARVOL DELTA

Immunomic Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022 (Businesswire) - "Immunomic Therapeutics...announced today that the company will be presenting two posters at the American Association for Cancer Research (AACR) Annual Meeting 2022 being held in New Orleans, Louisiana, from April 8-13. The posters to be presented at AACR are developed from the investigational nucleic acid platform, UNITE™ (UNiversal Intracellular Targeted Expression) for two vaccines, ITI-3000 for Merkel cell carcinoma and Her2/Neu-LAMP DNA vaccine, both which fuse a tumor associated antigen with lysosomal associated membrane protein 1 (LAMP-1)."

Preclinical • Merkel Cell Carcinoma • Non-melanoma Skin Cancer • Oncology • Skin Cancer